Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-28 Sale |
2023-11-30 9:51 pm |
SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C See Remarks |
7,381 | $27.49 | $202,931 | 30,041 (Direct) |
View |
| 2023-11-28 Sale |
2023-11-30 9:50 pm |
SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer |
53,505 | $27.49 | $1,471,049 | 135,778 (Direct) |
View |
| 2023-09-26 Purchase |
2023-09-28 3:45 pm |
SOLENO THERAPEUTICS INC | SLNO | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
866,789 | $17.44 | $15,113,916 | 3,324,542 (Indirect) |
View |
| 2023-06-02 Purchase |
2023-06-06 4:16 pm |
SOLENO THERAPEUTICS INC | SLNO | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
143,298 | $5.9574 | $853,681 | 2,207,753 (Indirect) |
View |
| 2023-05-30 Purchase |
2023-06-01 5:41 pm |
SOLENO THERAPEUTICS INC | SLNO | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
35,000 | $5.3764 | $188,175 | 2,064,455 (Indirect) |
View |
| 2023-05-19 Purchase |
2023-05-23 6:47 pm |
SOLENO THERAPEUTICS INC | SLNO | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
80,000 | $5.0759 | $406,075 | 1,944,455 (Indirect) |
View |
| 2022-12-09 Sale |
2023-05-15 4:04 pm |
SOLENO THERAPEUTICS INC | SLNO | SCHULER JACK W 10% Owner |
10,000 | $0.91 | $9,100 | 36,595 (Indirect) |
View |
| 2022-10-13 Sale |
2023-05-15 4:00 pm |
SOLENO THERAPEUTICS INC | SLNO | SCHULER JACK W 10% Owner |
420,071 | $1.1078 | $465,344 | 46,595 (Indirect) |
View |
| 2022-08-02 Sale |
2022-10-14 7:11 pm |
SOLENO THERAPEUTICS INC | SLNO | SCHULER JACK W 10% Owner |
180,523 | $2.703 | $487,962 | 1,270,888 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-02 Exercise |
2023-10-04 4:30 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner |
5,215,000 | $2.5 | 8,418,093 (Indirect) |
View |
| 2023-10-02 Exercise |
2023-10-04 4:30 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner |
5,215,000 | $0 | 8,418,093 (Indirect) |
View |
| 2023-09-28 Conversion |
2023-10-02 7:54 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP 10% Owner |
1,092,056 | $0 | 2,293,562 (Indirect) |
View |
| 2023-09-28 Conversion |
2023-10-02 7:54 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP 10% Owner |
1,092,056 | $1.75 | 2,293,562 (Indirect) |
View |
| 2023-09-26 Exercise |
2023-09-28 5:00 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner |
3,203,093 | $0 | 3,203,093 (Indirect) |
View |
| 2023-09-26 Exercise |
2023-09-28 5:00 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner |
3,203,093 | $1.75 | 3,203,093 (Indirect) |
View |
| 2023-08-15 Option Award |
2023-08-16 4:13 pm |
N/A 2033-08-15 |
SOLENO THERAPEUTICS INC | SLNO | Pauls Matthew Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-05-25 Option Award |
2023-06-05 8:13 pm |
N/A 2033-05-25 |
SOLENO THERAPEUTICS INC | SLNO | Volck Birgitte Director |
12,666 | $0 | 12,666 (Direct) |
View |
| 2023-05-26 Option Award |
2023-05-26 6:39 pm |
N/A 2033-05-26 |
SOLENO THERAPEUTICS INC | SLNO | Yen Kristen See Remarks |
116,523 | $0 | 120,955 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-26 6:30 pm |
N/A 2033-05-25 |
SOLENO THERAPEUTICS INC | SLNO | Sinclair Andrew Director |
12,666 | $0 | 12,666 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-26 6:30 pm |
N/A 2033-05-25 |
SOLENO THERAPEUTICS INC | SLNO | Melincoff Gwen A Director |
12,666 | $0 | 12,666 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-26 6:29 pm |
N/A 2033-05-25 |
SOLENO THERAPEUTICS INC | SLNO | MARIO ERNEST Director |
12,666 | $0 | 12,666 (Direct) |
View |
| 2023-05-26 Option Award |
2023-05-26 6:28 pm |
N/A 2033-05-26 |
SOLENO THERAPEUTICS INC | SLNO | Mackaness James H Chief Financial Officer |
116,335 | $0 | 120,821 (Direct) |
View |
| 2023-05-26 Option Award |
2023-05-26 6:28 pm |
N/A 2033-05-26 |
SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C See Remarks |
112,597 | $0 | 121,870 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-26 6:27 pm |
N/A 2033-05-25 |
SOLENO THERAPEUTICS INC | SLNO | Harris William G Director |
12,666 | $0 | 12,666 (Direct) |
View |
| 2023-05-26 Option Award |
2023-05-26 6:26 pm |
N/A 2033-05-26 |
SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer |
642,408 | $0 | 671,089 (Direct) |
View |
Ownership |
2023-05-18 4:31 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
0 | $0 | 1,864,455 (Indirect) |
View |
Ownership |
2023-05-15 5:01 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner |
0 | $0 | 8,418,093 (Indirect) |
View |
| 2023-05-08 Option Award |
2023-05-10 5:28 pm |
2023-05-08 N/A |
SOLENO THERAPEUTICS INC | SLNO | Mackaness James H Chief Financial Officer |
5,643 | $0.4425 | 5,643 (Direct) |
View |
| 2023-05-08 Option Award |
2023-05-10 5:28 pm |
2023-05-08 N/A |
SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer |
5,643 | $0.4425 | 5,643 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 6:12 pm |
N/A 2033-01-25 |
SOLENO THERAPEUTICS INC | SLNO | Yen Kristen See Remarks |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 6:11 pm |
N/A 2033-01-25 |
SOLENO THERAPEUTICS INC | SLNO | Mackaness James H Chief Financial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 6:11 pm |
N/A 2033-01-25 |
SOLENO THERAPEUTICS INC | SLNO | Hirano Patricia C See Remarks |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 6:10 pm |
N/A 2033-01-25 |
SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer |
115,000 | $0 | 115,000 (Direct) |
View |